The Role of Finerenone in the Management of Diabetic Nephropathy

Diabetic nephropathy (DN) is the leading cause of chronic kidney disease. Even though mineralocorticoid receptor antagonists (MRA) induce incremental reductions in urine albumin excretion when added to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, this combination is inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Veneti, Stavroula, Tziomalos, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266950/
https://www.ncbi.nlm.nih.gov/pubmed/34050896
http://dx.doi.org/10.1007/s13300-021-01085-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266950/
https://www.ncbi.nlm.nih.gov/pubmed/34050896
http://dx.doi.org/10.1007/s13300-021-01085-z

Ejemplares similares